Scleroderma is an autoimmune disorder—a rheumatic disease that causes inflammation in the skin and other areas of the body. The name scleroderma literally means “hard skin” because the inflammation triggers the body’s own immune system to make too much collagen, leading to the hardening and tightening of the skin and connective tissues (ie: fibrosis). In the most serious cases, there can be complications resulting in damage to the heart, lungs, and digestive system.
Scleroderma is best thought of as a single disease. However, it is a complex disease that can progress in very variable ways in individual patients. Some are affected early with aggressive changes while others have milder symptoms. The disease might progress quickly or slowly. This makes a concise definition—and diagnosis—difficult.
Raynaud’s phenomenon is a common medical condition, and women are much more likely to develop Raynaud’s phenomenon than men.
For people with scleroderma, skin ulcers most often appear at the tips of fingers (digital ulcers), may extend under the nails, or to the joints at pressure points.
Calcinosis is the abnormal collection of calcium salts which form under the skin and in muscles or tendons.
Telangiectasias are abnormal blood vessels that usually appear as red dots on the skin or may look like varicose veins, with a spider-web form.
Scleroderma can cause scar tissue in the lungs and thickening in the walls of blood vessels that carry blood to and from the heart to the lungs..
Interstitial Lung Disease (ILD) is another complication of systemic sclerosis which may affect breathing. Learn More
Most people living with scleroderma have gastrointestinal problems, which can involve different levels of risk, from simple indigestion to esophageal blockage.
The increased production of collagen associated with scleroderma can cause vascular dysfunction. This can contribute to stiffness and pain in the joints and muscles.
Symptoms of heart involvement in scleroderma depend on the location within the heart and the presence of any underlying conditions.
Kidney problems occur in ~15% of scleroderma patients, most often occurring with diffuse skin involvement and skin thickness in the upper arms and trunk.
Patients who are diagnosed with scleroderma are encouraged to receive care at a specialized Treatment Center.
View this guide to how you can prepare for your visits and be your own best advocate.
Dive deeper into understanding scleroderma through these in-depth webinars led by expert researchers and clinicians.
On our website, we share a glossary of terms that covers common terminology associated with scleroderma.
CONQUER is a registry that collects data about scleroderma patients to track and analyze the health status, disease complications, treatments, and outcomes of many patients over many years.
Clinical trials are a meaningful way to get involved with research and help find a cure. Search to find trials that are relevant to you.
Consider enrolling in the CONQUEST study, a scleroderma clinical trial developed by the SRF for people with systemic sclerosis-associated interstitial lung disease (SSc-ILD).